Patient Joins PQA23 Panel on IRA’s Potential Impact on Medication Access, Affordability
May 13th 2023At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, a patient joined a panel to give insight into the challenges of living with a chronic illness and what he sees as the pros and cons of the Inflation Reduction Act (IRA).
Read More
Q&A: Elizabeth Johnson Shares Why Empathy Is Missing From Patient-Centered Care
May 12th 2023Elizabeth Johnson, LPN, PACS, BPCA, CEO of MedicoCX, co-CEO of Healthcare Advocate Summit, and an Asembia 2023 presenter, discusses why more empathetic approaches that take into account the full range of the patient experience are needed to improve patient-focused health care.
Read More
Dr Jessica Robinson-Papp Explains Toxicity Reduction in HIV Treatment
May 12th 2023Jessica Robinson-Papp, MD, MS, professor of neurology at the Icahn School of Medicine at Mount Sinai, talks about the strides made in antiretroviral therapy for HIV and how these improvements lead to better patient outcomes.
Watch
IQVIA’s Luke Greenwalt on Increasing Payer Pressures: We Can Change the Path We’re On
May 11th 2023“As we look over the next decade, the climb is going to be steep, it's going to be challenging, but success is still possible,” said Luke Greenwalt, vice president of market access at IQVIA, during his session at Asembia 2023.
Read More
Specialty Pharmacies Should Leverage AI Tracking to Increase Drug Delivery Efficiency
May 10th 2023Speakers at the 2023 Asembia Specialty Pharmacy Summit outlined how artificial intelligence (AI) tools for pharmaceuticals, such as parcel tracking, could reduce operational costs for specialty pharmacies and mitigate drug delivery issues for patients.
Read More
Dr Milena Pavlova Emphasizes the Importance of Sleep Apnea Treatment in Epilepsy
May 10th 2023Milena Pavlova, MD, neurologist, and medical director of the Sleep Testing Center at Brigham and Women’s Faulkner Hospital, highlights how even mild cases of sleep apnea can increase the number of seizures a patient with epilepsy experiences and harm organs.
Watch
Removing the Taboo: Talking About Women’s Health Is the First Step to Improving Health Equity
May 9th 2023A panel on women’s health disparities at the 2023 Asembia Specialty Pharmacy Summit addressed the current challenges women face regarding health care as well as how digital tools, collaboration between clinics and governments, and more detailed and inclusive research can help improve health equity for all women.
Read More
Dr Fran Gregory Discusses the Impact of the New Wave of Biosimilars on Rebate Practices
May 8th 2023Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health, discusses the role the new wave of biosimilars will have on rebate practices for both pharmacy benefit managers (PBMs) and payers.
Watch
Dr Jessica Robinson-Papp Talks About HIV Medication Adherence and Supporting Patients
May 5th 2023Jessica Robinson-Papp, MD, MS, professor of neurology at Icahn School of Medicine at Mt. Sinai, talks about what factors can contribute to medication nonadherence in people with HIV, and the different levels of support that might be available to patients.
Watch
Sebastian Pistritto: Harnessing Data Boosts Efficiency in Medication Delivery
May 4th 2023Sebastian Pistritto, chief marketing officer at ParcelShield Holdings, LLC, talks about how technology such as artificial intelligence helps to evaluate data to assist in medication delivery service decision-making, depending on the need of the pharmacy and its patients.
Watch
Julie Reed: The Status Quo for Biosimilars Needs to Change to Maintain the Industry
May 4th 2023The 2023 Asembia Specialty Pharmacy Summit featured Juliana (Julie) Reed, executive director of the Biosimilars Forum, who spoke on the challenges still facing the biosimilars industry and how they may impact the success of adalimumab biosimilars in the United States.
Read More
Dr David Spencer Emphasizes Safety in Investigational Cell Therapy for Epilepsy Trial
May 4th 2023David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University, discusses the importance of patient safety in a first-in-human trial of NRTX-1001 GABAergic interneuron cell therapy for focal epilepsy.
Watch
Cardinal Health's Naveen Mansukhani Details How Lowering Costs Is a Multi-Department Effort
May 3rd 2023Naveen Mansukhani, director of operations and account management of Retail Pharmacy Services at Cardinal Health, talks about how the responsibility for saving costs does not just fall on one department or person, but is collaborative and requires strategy.
Watch
NHIA's Connie Sullivan Discusses the Benefits and Patient Satisfaction of Home Infusion
May 3rd 2023Connie Sullivan, president and CEO of the National Home Infusion Association (NHIA), discusses why at-home infusion is beneficial to patients and why so many patients reported feeling satisfied with home administration.
Watch
Dr David Spencer Looks Ahead to Next Phase of Cell Therapy Trial for Epilepsy
May 3rd 2023David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University, talks about the first-in-human trial of interneuron cell therapy for treatment of focal epilepsy and explains the next steps.
Watch
Digital Tools May Help Improve Patient Experience, but Human Connection Is Still Needed
May 3rd 2023Although digital tools can be immensely helpful for creating a personalized, convenient interaction between patients and the health care system, they should not be the end-all be-all method to improve the patient experience, according to a panel discussion at the 2023 Asembia Specialty Pharmacy Summit.
Read More
Josh Marsh Discusses the Role of Technology, Automation in Patient Assistance Programs
May 2nd 2023Technology and automation within patient assistance programs can enhance the patient journey and assist pharmaceutical manufacturers at a lower cost, explained Josh Marsh, vice president of Sonexus at Cardinal Health.
Watch
Survey Shows Payers More Likely to Prefer Multiple Biosimilars for the Same Reference Product
May 2nd 2023In a panel at the 2023 Asembia Specialty Pharmacy Summit, speakers presented on the payer perspective regarding biosimilars, including that they feel comfortable preferring multiple biosimilars for the same reference product and are looking for interchangeability designations.
Read More
Dr Andy Blauvelt on Selecting the Right Patient for Systemic Therapy or Biologics to Treat AD
May 2nd 2023Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, discusses the use of systemic therapies vs biologics and why adherence is so important when treating patients with atopic dermatitis (AD).
Watch
Dr Larry Eichenfield: A Changing Therapy Landscape Provides More Options for Infants With AD
May 2nd 2023Larry Eichenfield, MD, professor of dermatology and pediatrics and vice chair of the Department of Dermatology at the University of California San Diego School of Medicine and chief of pediatric and adolescent dermatology at Rady Children's Hospital San Diego, discusses the use of different treatments and biologics for atopic dermatitis (AD) in infants, which he presented at the Revolutionizing Atopic Dermatitis conference.
Read More
Payers, Drug Manufacturers Can Expect More Liability Under New IRA Drug Pricing Policies
May 2nd 2023Panelists at the 2023 Asembia Specialty Pharmacy Summit discussed the myriad of ways that the drug pricing policies of the Inflation Reduction Act (IRA), such as inflation rebates and a redesign of Medicare Part D plans, will affect payers and manufacturers.
Watch